Global Bovine Babesiosis Treatment Market Overview:
Bovine babesiosis is a tick-borne disease of cattle caused by protozoan parasites. It is the most significant arthropod-borne disease of cattle worldwide. Bovine babesiosis causes significant morbidity and mortality. The most prevalent protozoan species that cause the disease are Babesia bovis and B. bigemina. These two species are found throughout all tropical and subtropical regions. Symptoms of the disease usually appear within two to three weeks of tick infestation. Animals infected with Babesia bovis and B. bigemina develop anorexia, high fever, diarrhea or constipation, muscle tremor, hemoglobinuria, etc. Older animals are more affected by this disease. Abortions may occur in pregnant animals severely affected by bovine babesiosis.
- Increase in the Incidence of Babesiosis among Cattle
- Rising Awareness Regarding Animal Health
- Upsruging Demand for PCR assays in Laboratories
- Resistance to Antibiotics
- Technological Development and Advancement in the Bovine Babesiosis Treatment
- Lack of Vaccines that Prevent the Transmission of Babesiosis
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are GlaxoSmithKline, plc (United Kingdom), Merck & Co., Inc. (United States), Limor de Colombia (Colombia), Onderstepoort Biological Products SOC Ltd (South Africa), Letopharm Limited (China), Biogenesis-Bago (Argentina), Heska Corporation (United States), Colorado Serum (United States), Boehringer Ingelheim (Germany), SYVA Laboratorios (Spain) and Lohmann Animal Health (Germany). Considering Market by Vaccine, the sub-segment i.e. Live-Attenuated Vaccines will boost the Bovine Babesiosis Treatment market. Considering Market by Drug Class, the sub-segment i.e. Antiprotozoal Agents will boost the Bovine Babesiosis Treatment market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Bovine Babesiosis Treatment market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Bovine Babesiosis Treatment market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Bovine Babesiosis Treatment Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.